Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
US Army
Harvard Business School
Covington
McKinsey
Cipla
Accenture
Baxter

Generated: November 13, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Bitopertin

« Back to Dashboard

US Patents for Bitopertin

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Bitopertin ➤ Try a Free Trial Benzoyl-piperazine derivatives Hoffmann-La Roche Inc. (Nutley, NJ) ➤ Try a Free Trial
Bitopertin ➤ Try a Free Trial Benzoyl-piperazine derivatives Hoffmann-La Roche Inc. (Nutley, NJ) ➤ Try a Free Trial
Bitopertin ➤ Try a Free Trial Synthesis of GlyT-1 inhibitors Hoffman-La Roche Inc. (Nutley, NJ) ➤ Try a Free Trial
Bitopertin ➤ Try a Free Trial Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- fonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone Hoffmann-La Roche Inc. (Nutley, NJ) ➤ Try a Free Trial
Bitopertin ➤ Try a Free Trial 5-HT3 receptor antagonists Takeda Pharmaceutical Company Limited (Osaka, JP) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Bitopertin

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Bitopertin Argentina 045360 2023-08-11 ➤ Try a Free Trial
Bitopertin Austria 382611 2023-08-11 ➤ Try a Free Trial
Bitopertin Australia 2004263306 2023-08-11 ➤ Try a Free Trial
Bitopertin Brazil PI0413497 2023-08-11 ➤ Try a Free Trial
Bitopertin Canada 2534675 2023-08-11 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Queensland Health
QuintilesIMS
Baxter
Federal Trade Commission
Harvard Business School
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: